Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy

Photodynamic therapy (PDT) combined with intravitreal anti-vascular endothelial growth factor (VEGF) agents is currently the first-line treatment for polypoidal choroidal vasculopathy (PCV), along with anti-VEGF monotherapy. In this study, 100 eyes with treatment-naïve PCV were initially treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikushima, Wataru, Sakurada, Yoichi, Sugiyama, Atsushi, Yoneyama, Seigo, Tanabe, Naohiko, Matsubara, Mio, Mabuchi, Fumihiko, Iijima, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705714/
https://www.ncbi.nlm.nih.gov/pubmed/29184088
http://dx.doi.org/10.1038/s41598-017-16476-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705714/
https://www.ncbi.nlm.nih.gov/pubmed/29184088
http://dx.doi.org/10.1038/s41598-017-16476-1

Ejemplares similares